5 Tiny Cryptos That Could Soar During 2024 Crypto Bull Run One of the first ever crypto millionaires who bought Bitcoin when it was trading for just $5 in 2011 is back with his next huge prediction. A newly approved government regulation is set to flood trillions of dollars into the crypto markets, leading to the FINAL crypto bull run. One of the "Kings of Crypto" has revealed five tiny cryptos that could soar over the course of 2024. Potentially resulting in gains as big as 10X, 50X, or even 100X over the next 12 months.

Get His #1 Coin For 2024 FREE By Clicking Here

ZNTL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.10%

Insider Buying (Last 12 Months): $108,081,010.00

Insider Selling (Last 12 Months): $3,613,314.60

Zentalis Pharmaceuticals Insider Trading History Chart

Zentalis Pharmaceuticals Share Price & Price History

^$11.77

▼ -0.8 (-6.36%)

As of 04/24/2024 01:00 AM ET

Days: 30 | 90 | 365

The A.I. story nobody is telling you (Read ASAP)

From TradeSmith | Ad

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

Click here to see Louis' new video for yourself.

Zentalis Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/12/2024	Cam Gallagher	President	Sell	1,173	$11.44	$13,419.12	643,277
2/12/2024	Melissa B. Epperly	CFO	Sell	2,573	$11.44	$29,435.12	451,449
11/13/2023	Kimberly Blackwell	CEO	Buy	5,000	$10.29	$51,450.00	254,800
11/10/2023	David Michael Johnson	Director	Buy	17,000	$9.88	$167,960.00	144,389
10/4/2023	Carrie Brownstein	Insider	Sell	10,628	$19.50	$207,246.00	105,685
10/4/2023	Melissa B. Epperly	CFO	Sell	5,482	$19.50	$106,899.00	387,691
9/11/2023	Jan Skvarka	Director	Sell	5,000	$25.05	$125,250.00	47,970
6/20/2023	Matrix Capital Management Comp	Major Shareholder	Buy	4,760,000	$22.66	$107,861,600.00	13,959,973
5/31/2023	Cam Gallagher	President	Sell	27,768	$26.27	$729,465.36	463,502
5/26/2023	Kevin D. Bunker	Insider	Sell	80,000	$30.02	$2,401,600.00	15,000
2/13/2023	Cam Gallagher	President	Sell	3,332	$20.42	$68,039.44	499,771
2/13/2023	Kevin D. Bunker	Insider	Sell	3,807	$20.42	$77,738.94	871,657
2/13/2023	Melissa B. Epperly	CFO	Sell	2,624	$20.42	$53,582.08	397,275
2/6/2023	Cam Gallagher	President	Sell	10,000	$22.27	$222,700.00	503,103
1/17/2023	Cam Gallagher	President	Sell	10,000	$24.15	$241,500.00	352,011
1/5/2023	Cam Gallagher	President	Sell	10,000	$21.02	$210,200.00	362,011
11/15/2022	Cam Gallagher	President	Sell	12,500	$22.77	$284,625.00	372,011
11/7/2022	Cam Gallagher	President	Sell	12,500	$23.67	$295,875.00	396,885
10/17/2022	Cam Gallagher	President	Sell	12,500	$23.51	$293,875.00	409,385
10/5/2022	Cam Gallagher	President	Sell	12,500	$22.32	$279,000.00	431,885
9/15/2022	Cam Gallagher	President	Sell	12,500	$25.26	$315,750.00	454,385
7/20/2022	Kevin D. Bunker	COO	Sell	5,000	$30.00	$150,000.00	100,000
7/13/2022	Kevin D. Bunker	COO	Sell	1,710	$30.02	$51,334.20	108,290
7/5/2022	Kevin D. Bunker	COO	Sell	25,000	$30.07	$751,750.00	110,000
4/11/2022	Kevin D. Bunker	COO	Sell	5,000	$30.55	$152,750.00	135,000
4/5/2022	Cam Gallagher	Director	Sell	10,000	$50.48	$504,800.00	355,813
4/4/2022	Anthony Y. Sun	CEO	Sell	10,471	$48.50	$507,843.50	1,175,589
4/4/2022	Melissa B. Epperly	CFO	Sell	17,080	$50.09	$855,537.20	247,414
3/21/2022	Kevin D. Bunker	COO	Sell	10,000	$49.07	$490,700.00
3/15/2022	Cam Gallagher	Director	Sell	10,000	$41.92	$419,200.00
3/10/2022	Kevin D. Bunker	COO	Sell	10,000	$46.94	$469,400.00
3/7/2022	Cam Gallagher	Director	Sell	10,000	$44.94	$449,400.00
3/1/2022	Anthony Y. Sun	CEO	Sell	10,471	$49.79	$521,351.09
2/23/2022	Melissa B. Epperly	CFO	Sell	1,913	$49.10	$93,928.30
2/22/2022	Kevin D. Bunker	COO	Sell	10,000	$49.09	$490,900.00
2/14/2022	Alexis Pinto	Insider	Sell	691	$50.23	$34,708.93
2/14/2022	Anthony Y. Sun	CEO	Sell	4,733	$50.23	$237,738.59
2/14/2022	Cam Gallagher	Director	Sell	7,188	$50.19	$360,765.72
2/14/2022	Dimitris Voliotis	SVP	Sell	601	$50.23	$30,188.23
2/14/2022	Kevin D. Bunker	COO	Sell	4,688	$50.26	$235,618.88
2/10/2022	Kevin D. Bunker	COO	Sell	10,000	$53.50	$535,000.00
2/7/2022	Cam Gallagher	Director	Sell	10,000	$53.45	$534,500.00
2/1/2022	Anthony Y. Sun	CEO	Sell	10,471	$57.58	$602,920.18
1/20/2022	Dimitris Voliotis	SVP	Sell	10,000	$60.63	$606,300.00
1/18/2022	Cam Gallagher	Director	Sell	10,000	$62.64	$626,400.00
1/10/2022	Kevin D. Bunker	COO	Sell	10,000	$68.41	$684,100.00
1/5/2022	Cam Gallagher	Director	Sell	10,000	$75.49	$754,900.00
1/3/2022	Anthony Y. Sun	CEO	Sell	10,471	$80.07	$838,412.97
1/3/2022	Kimberly Blackwell	Director	Sell	1,000	$83.74	$83,740.00
12/20/2021	Kevin D. Bunker	COO	Sell	10,000	$79.24	$792,400.00
12/15/2021	Cam Gallagher	Director	Sell	10,000	$74.03	$740,300.00
12/10/2021	Kevin D. Bunker	COO	Sell	10,000	$71.71	$717,100.00
12/6/2021	Cam Gallagher	Director	Sell	10,000	$71.33	$713,300.00
12/1/2021	Anthony Y. Sun	CEO	Sell	10,471	$77.98	$816,528.58
12/1/2021	Kimberly Blackwell	Director	Sell	1,000	$81.84	$81,840.00
11/22/2021	Kevin D. Bunker	COO	Sell	10,000	$75.99	$759,900.00
11/15/2021	Cam Gallagher	Director	Sell	10,000	$75.36	$753,600.00
11/10/2021	Kevin D. Bunker	COO	Sell	10,000	$78.15	$781,500.00
11/5/2021	Cam Gallagher	Director	Sell	10,000	$82.95	$829,500.00
11/1/2021	Anthony Y. Sun	CEO	Sell	10,471	$81.44	$852,758.24
11/1/2021	Kimberly Blackwell	Director	Sell	1,000	$80.46	$80,460.00
10/25/2021	Alexis Pinto	Insider	Sell	30,000	$77.73	$2,331,900.00
10/25/2021	Kimberly Blackwell	Director	Sell	1,000	$77.59	$77,590.00
10/4/2021	Anthony Y. Sun	CEO	Sell	26,799	$66.33	$1,777,577.67
10/4/2021	David Michael Johnson	Director	Sell	12,896	$66.35	$855,649.60
10/1/2021	Cam Gallagher	Director	Sell	10,000	$66.15	$661,500.00
10/1/2021	Kevin D. Bunker	COO	Sell	8,420	$66.13	$556,814.60
9/1/2021	Anthony Y. Sun	CEO	Sell	26,794	$67.50	$1,808,595.00
9/1/2021	Cam Gallagher	Director	Sell	10,000	$67.52	$675,200.00	470,962
9/1/2021	Kevin D. Bunker	COO	Sell	8,420	$67.49	$568,265.80	994,841
8/18/2021	Melissa B. Epperly	CFO	Buy	1,326	$52.00	$68,952.00	258,400
8/2/2021	Anthony Y. Sun	CEO	Sell	19,015	$51.03	$970,335.45
8/2/2021	Cam Gallagher	Director	Sell	10,000	$51.02	$510,200.00	483,419
8/2/2021	Kevin D. Bunker	COO	Sell	8,420	$51.05	$429,841.00	994,841
7/6/2021	Anthony Y. Sun	CEO	Sell	25,045	$46.90	$1,174,610.50
7/6/2021	Cam Gallagher	Director	Sell	15,798	$46.88	$740,610.24
7/6/2021	Kevin D. Bunker	COO	Sell	20,298	$46.90	$951,976.20	1,014,747
7/2/2021	Cam Gallagher	Director	Sell	10,000	$49.58	$495,800.00
7/1/2021	Anthony Y. Sun	CEO	Sell	26,794	$51.21	$1,372,120.74
7/1/2021	Kevin D. Bunker	COO	Sell	8,420	$51.23	$431,356.60	1,019,653
7/1/2021	Melissa B. Epperly	CFO	Sell	3,083	$51.27	$158,065.41	259,457
6/1/2021	Anthony Y. Sun	CEO	Sell	26,794	$54.03	$1,447,679.82	1,423,491
6/1/2021	Cam Gallagher	Director	Sell	10,000	$54.06	$540,600.00	516,845
6/1/2021	Kevin D. Bunker	COO	Sell	8,420	$54.09	$455,437.80	1,019,653
6/1/2021	Melissa B. Epperly	CFO	Sell	3,083	$54.05	$166,636.15	260,357
5/3/2021	Anthony Y. Sun	CEO	Sell	26,794	$59.32	$1,589,420.08	1,474,161
5/3/2021	Cam Gallagher	Director	Sell	10,000	$59.25	$592,500.00	534,373
5/3/2021	Kevin D. Bunker	COO	Sell	8,420	$59.24	$498,800.80	1,019,653
5/3/2021	Melissa B. Epperly	CFO	Sell	3,083	$59.24	$182,636.92	265,973

The "Smart Money" Is Ready for May 1st Are You?

From Stansberry Research | Ad

Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company.

One Former Wall St. Trader Explains Why…

SEC Filings (Institutional Ownership Changes) for Zentalis Pharmaceuticals (NASDAQ:ZNTL)

Institutional Buying and Selling by Quarter

Zentalis Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/16/2024	Wealth Enhancement Advisory Services LLC	43,175	$0.68M	0.0%	N/A	0.061%
4/5/2024	Los Angeles Capital Management LLC	38,468	$0.61M	0.0%	N/A	0.054%
2/20/2024	Eventide Asset Management LLC	11,559,975	$175.13M	2.9%	+47.9%	16.291%
2/15/2024	Birchview Capital LP	16,000	$0.24M	0.2%	N/A	0.023%
2/14/2024	Pennant Investors LP	32,400	$0.49M	0.1%	N/A	0.046%
2/14/2024	Verition Fund Management LLC	344,617	$5.22M	0.0%	-35.9%	0.487%
2/14/2024	Sectoral Asset Management Inc.	7,355	$0.11M	0.0%	-98.1%	0.010%
2/13/2024	Tower Research Capital LLC TRC	3,615	$55K	0.0%	+252.3%	0.005%
2/13/2024	Capital International Investors	2,819,664	$42.72M	0.0%	-9.9%	3.984%
2/13/2024	Rafferty Asset Management LLC	360,125	$5.46M	0.0%	+79.4%	0.509%
2/12/2024	Decheng Capital LLC	2,099,583	$31.81M	8.9%	N/A	2.967%
2/12/2024	TD Asset Management Inc	190,168	$2.88M	0.0%	+5.2%	0.269%
2/9/2024	Primecap Management Co. CA	1,023,350	$15.50M	0.0%	-1.0%	1.446%
2/9/2024	Quest Partners LLC	2,482	$38K	0.0%	N/A	0.004%
2/7/2024	Teacher Retirement System of Texas	11,425	$0.17M	0.0%	-18.5%	0.016%
2/7/2024	E Fund Management Co. Ltd.	19,340	$0.29M	0.0%	+87.6%	0.027%
2/6/2024	Charles Schwab Investment Management Inc.	445,823	$6.75M	0.0%	+0.9%	0.630%
2/6/2024	Swiss National Bank	97,400	$1.48M	0.0%	-10.1%	0.138%
2/1/2024	Handelsbanken Fonder AB	13,500	$0.21M	0.0%	N/A	0.019%
1/31/2024	abrdn plc	40,156	$0.61M	0.0%	N/A	0.057%
1/31/2024	Federated Hermes Inc.	2,160,565	$32.73M	0.1%	+10.9%	3.053%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	40,574	$0.62M	0.0%	+17.1%	0.057%
1/24/2024	China Universal Asset Management Co. Ltd.	8,188	$0.12M	0.0%	+352.6%	0.012%
1/23/2024	Regency Capital Management Inc. DE	29,800	$0.45M	0.3%	+98.7%	0.042%
1/18/2024	Values First Advisors Inc.	48,068	$0.73M	0.4%	+17.5%	0.068%
1/12/2024	SG Americas Securities LLC	152,747	$2.31M	0.0%	+4.3%	0.216%
1/11/2024	OneAscent Financial Services LLC	10,324	$0.16M	0.0%	N/A	0.015%
1/5/2024	Exchange Traded Concepts LLC	5,989	$91K	0.0%	+34.0%	0.008%
12/18/2023	Vanguard Group Inc.	5,236,663	$105.05M	0.0%	+6.2%	7.400%
12/1/2023	Wellington Management Group LLP	1,917,105	$38.46M	0.0%	+0.5%	2.709%
11/15/2023	Sectoral Asset Management Inc.	386,525	$7.75M	1.5%	+65.2%	0.546%
11/15/2023	Kennedy Capital Management LLC	156,475	$3.14M	0.1%	+2.7%	0.221%
11/15/2023	Adage Capital Partners GP L.L.C.	301,667	$6.05M	0.0%	-45.6%	0.426%
11/15/2023	Alps Advisors Inc.	52,125	$1.05M	0.0%	+19.2%	0.074%
11/14/2023	Eventide Asset Management LLC	7,814,039	$156.75M	2.8%	+13.6%	11.041%
11/14/2023	Avidity Partners Management LP	2,100,000	$42.13M	1.7%	-10.0%	2.967%
11/14/2023	Qube Research & Technologies Ltd	141,388	$2.84M	0.0%	N/A	0.200%
11/14/2023	Trexquant Investment LP	24,516	$0.49M	0.0%	-39.4%	0.035%
11/14/2023	Primecap Management Co. CA	1,033,750	$20.74M	0.0%	-7.0%	1.461%
11/14/2023	Profund Advisors LLC	34,176	$0.69M	0.0%	-24.9%	0.048%
11/13/2023	Federated Hermes Inc.	1,947,693	$39.07M	0.1%	-3.5%	2.752%
11/13/2023	Healthcare of Ontario Pension Plan Trust Fund	47,000	$0.94M	0.0%	+176.5%	0.066%
11/13/2023	FMR LLC	9,493,896	$190.45M	0.0%	-10.2%	13.415%
11/13/2023	Rafferty Asset Management LLC	200,686	$4.03M	0.0%	-20.0%	0.284%
11/13/2023	E Fund Management Co. Ltd.	10,307	$0.21M	0.0%	-23.6%	0.015%
11/9/2023	Deutsche Bank AG	32,080	$0.64M	0.0%	-92.3%	0.045%
11/8/2023	State Board of Administration of Florida Retirement System	16,619	$0.33M	0.0%	+19.1%	0.023%
11/8/2023	Charles Schwab Investment Management Inc.	442,064	$8.87M	0.0%	+8.9%	0.625%
11/8/2023	Swiss National Bank	108,400	$2.18M	0.0%	-11.6%	0.153%
11/8/2023	Values First Advisors Inc.	40,920	$0.82M	0.5%	+33.9%	0.058%
11/7/2023	Barclays PLC	110,817	$2.22M	0.0%	-47.8%	0.157%
11/7/2023	Arizona State Retirement System	14,046	$0.28M	0.0%	+20.2%	0.020%
11/2/2023	Regency Capital Management Inc. DE	15,000	$0.30M	0.3%	N/A	0.021%
10/31/2023	Teacher Retirement System of Texas	14,013	$0.28M	0.0%	-8.2%	0.020%
10/31/2023	China Universal Asset Management Co. Ltd.	1,809	$36K	0.0%	+132.2%	0.003%
10/27/2023	TD Asset Management Inc	180,768	$3.63M	0.0%	+76.1%	0.256%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	34,657	$0.70M	0.0%	+14.0%	0.049%
10/24/2023	Bank of New York Mellon Corp	242,109	$4.86M	0.0%	+47.1%	0.342%
10/23/2023	Commonwealth Equity Services LLC	16,980	$0.34M	0.0%	+65.7%	0.024%
10/18/2023	Exchange Traded Concepts LLC	4,470	$90K	0.0%	-20.9%	0.006%
10/13/2023	SG Americas Securities LLC	146,495	$2.94M	0.0%	+99.0%	0.207%
8/15/2023	Boxer Capital LLC	450,000	$12.70M	0.6%	N/A	0.637%
8/14/2023	Matrix Capital Management Company LP	13,959,973	$393.81M	4.6%	+51.7%	19.771%
8/14/2023	NinePointTwo Capital LLC	10,716	$0.30M	0.1%	N/A	0.015%
8/14/2023	Cormorant Asset Management LP	1,095,000	$30.89M	1.7%	N/A	1.551%
8/14/2023	ArrowMark Colorado Holdings LLC	87,640	$2.47M	0.0%	N/A	0.124%
8/14/2023	Jefferies Financial Group Inc.	93,900	$2.65M	0.0%	N/A	0.133%
8/14/2023	Deep Track Capital LP	300,300	$8.47M	0.4%	N/A	0.425%
8/14/2023	Prelude Capital Management LLC	10,017	$0.28M	0.0%	N/A	0.014%
8/11/2023	Trexquant Investment LP	40,458	$1.14M	0.0%	+75.2%	0.068%
8/11/2023	E Fund Management Co. Ltd.	13,492	$0.38M	0.0%	+14.1%	0.023%
8/11/2023	ExodusPoint Capital Management LP	18,410	$0.52M	0.0%	-75.3%	0.031%
8/10/2023	MetLife Investment Management LLC	25,544	$0.72M	0.0%	+2.4%	0.043%
8/10/2023	ProShare Advisors LLC	10,237	$0.29M	0.0%	N/A	0.017%
8/10/2023	Profund Advisors LLC	45,531	$1.28M	0.1%	+17.1%	0.077%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	30,404	$0.86M	0.0%	+1.9%	0.051%
8/10/2023	Russell Investments Group Ltd.	105,873	$2.99M	0.0%	+92.3%	0.178%
8/10/2023	Tekla Capital Management LLC	40,156	$1.13M	0.0%	N/A	0.068%
8/10/2023	Citigroup Inc.	85,407	$2.41M	0.0%	-54.7%	0.144%
8/9/2023	Mayo Clinic	187,143	$5.28M	5.4%	-37.0%	0.315%
8/9/2023	TD Asset Management Inc	102,628	$2.90M	0.0%	+24.1%	0.173%
8/9/2023	Swiss National Bank	122,600	$3.46M	0.0%	+24.5%	0.206%
8/8/2023	Rhumbline Advisers	66,800	$1.88M	0.0%	+3.2%	0.112%
8/7/2023	Principal Financial Group Inc.	14,081	$0.40M	0.0%	+4.5%	0.024%
8/4/2023	American International Group Inc.	23,646	$0.67M	0.0%	+4.4%	0.040%
8/3/2023	Barclays PLC	212,415	$5.99M	0.0%	+136.1%	0.301%
8/3/2023	Bank of New York Mellon Corp	164,537	$4.64M	0.0%	+5.8%	0.277%
8/2/2023	Values First Advisors Inc.	30,558	$0.86M	0.5%	+300.2%	0.051%
8/2/2023	Handelsbanken Fonder AB	8,300	$0.23M	0.0%	N/A	0.014%
8/1/2023	Arizona State Retirement System	11,683	$0.33M	0.0%	-11.7%	0.020%
7/28/2023	Decheng Capital Management III Cayman LLC	2,099,583	$59.23M	18.6%	+15.1%	3.529%
7/24/2023	Scharf Investments LLC	7,531	$0.21M	0.0%	N/A	0.013%
7/20/2023	Exchange Traded Concepts LLC	5,654	$0.16M	0.0%	N/A	0.010%
7/19/2023	Teacher Retirement System of Texas	15,258	$0.43M	0.0%	+8.5%	0.026%
7/10/2023	SG Americas Securities LLC	73,634	$2.08M	0.0%	N/A	0.124%
5/12/2023	Sectoral Asset Management Inc.	234,000	$4.03M	0.8%	+16.4%	0.394%
5/12/2023	Wellington Management Group LLP	3,360,329	$57.80M	0.0%	-7.1%	5.652%
5/12/2023	Profund Advisors LLC	38,888	$0.67M	0.0%	N/A	0.065%
5/11/2023	FMR LLC	8,912,751	$153.30M	0.0%	+12.7%	14.992%
5/11/2023	ExodusPoint Capital Management LP	74,592	$1.28M	0.0%	-12.9%	0.125%

Data available starting January 2016

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its products candidatures include the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase for the treatment of inhibitor for advanced solid tumors and hematological malignancies; in Phase 2 clinical trial as a monotherapy for the treatment of uterine serous carcinoma indications; Phase 2 clinical trial in Cyclin E1 driven high-grade serous ovarian cancer, fallopian tube, or primary peritoneal cancer; Phase 1/2 clinical trial in combination with PARPi for platinum-resistant ovarian cancer; Phase 1b clinical trial in combination with chemotherapy in platinum-resistant ovarian, and peritoneal or fallopian tube cancer; Phase 1/2 clinical trial in combination with chemotherapy in relapsed or refractory osteosarcoma; Phase 1/2 clinical trial with encorafenib and cetuximab for mutant metastatic colorectal cancer; and Phase 1/2 clinical trial in combination with chemotherapy in pancreatic cancer. The company's products pipeline also includes ZN-d5, an oral small molecule inhibitor of B-cell lymphoma 2, for hematological malignancies and related disorders; and BCL-xL heterobifunctional degrader, a member of the anti-apoptotic BCL-2 proteins, for solid tumors and hematological malignancies. Zentalis Pharmaceuticals, Inc. has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC; Pfizer, Inc.; Zentera Therapeutics; Dana-Farber; and GlaxoSmithKline plc. The company was incorporated in 2014 and is headquartered in New York, New York.

Today's Range

Now: $11.77

$11.63

$12.59

50 Day Range

MA: $14.16

$11.95

$16.13

52 Week Range

Now: $11.77

$9.56

$31.46

Volume

854,473 shs

Average Volume

797,276 shs

Market Capitalization

$835.20 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.73

Who are the company insiders with the largest holdings of Zentalis Pharmaceuticals?: Zentalis Pharmaceuticals' top insider investors include:
Matrix Capital Management Comp (Major Shareholder)
Kevin D Bunker (Insider)
Cam Gallagher (President)
Melissa B Epperly (CFO)
Kimberly Blackwell (CEO)
David Michael Johnson (Director)
Kevin D Bunker (COO)
Carrie Brownstein (Insider)
Jan Skvarka (Director)
Learn More about top insider investors at Zentalis Pharmaceuticals.
Who are the major institutional investors of Zentalis Pharmaceuticals?: Zentalis Pharmaceuticals' top institutional shareholders include:
Wealth Enhancement Advisory Services LLC — 0.06%
Los Angeles Capital Management LLC — 0.05%
Learn More about top institutional investors of Zentalis Pharmaceuticals stock.
Which major investors are buying Zentalis Pharmaceuticals stock?: In the last quarter, ZNTL stock was acquired by institutional investors including:
Wealth Enhancement Advisory Services LLC
Los Angeles Capital Management LLC
In the last year, these company insiders have bought Zentalis Pharmaceuticals stock:
Matrix Capital Management Comp (Major Shareholder)
Kevin D Bunker (Insider)
Cam Gallagher (President)
Learn More investors buying Zentalis Pharmaceuticals stock.

The #1 Crypto for 2024

From InvestorPlace | Ad